Novavax COVID-19 vaccine: no new safety concerns

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1971卷 / 1期
关键词：
D O I：
10.1007/s40278-023-45135-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [41] A New Vaccine to Battle Covid-19
    Haynes, Barton F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05): : 470 - 471
  • [42] COVID-19 vaccine errors dominate ISMP's list of top 10 safety concerns for 2021
    Reactions Weekly, 2022, 1893 (1) : 2 - 2
  • [43] The Novavax vaccine had 90% efficacy against COVID-19 ≥7 d after the second dose
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : JC124 - JC124
  • [44] Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase
    Macias Saint-Gerons, Diego
    Ibarz, Maria Teresa
    Castro, Jose Luis
    Fores-Martos, Jaume
    Tabares-Seisdedos, Rafael
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (02) : 263 - 270
  • [45] Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase
    Diego Macías Saint-Gerons
    María Teresa Ibarz
    José Luis Castro
    Jaume Forés-Martos
    Rafael Tabarés-Seisdedos
    Drugs - Real World Outcomes, 2023, 10 : 263 - 270
  • [46] Safety concerns with higher dosage chloroquine in COVID-19 patients
    Reactions Weekly, 2020, 1802 (1) : 11 - 11
  • [47] Repurposed Drugs Against COVID-19: Safety Concerns and Stockout
    Khan, Jehan Zeb
    Ali, Iftikhar
    Hassan, Zair
    HOSPITAL PHARMACY, 2020, 55 (04) : 218 - 219
  • [48] COVID-19 vaccines: concerns beyond protective efficacy and safety
    Lai, Chih-Cheng
    Chen, I-Tzu
    Chao, Chien-Ming
    Lee, Ping-Ing
    Ko, Wen-Chien
    Hsueh, Po-Ren
    EXPERT REVIEW OF VACCINES, 2021, 20 (08) : 1013 - 1025
  • [49] Safety Concerns Of Drugs And Vaccines Used In The Treatment Of COVID-19
    Ghai, Roma
    Goel, Richa
    Singh, Aarti
    Bhatt, Pankaj
    Shishodia, Tarun
    Yadav, Deeksha
    Nagarajan, Kandasamy
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 1665 - 1673
  • [50] Safety of seven COVID-19 vaccine booster doses
    Reactions Weekly, 2021, 1885 (1) : 11 - 11
12345